Zhonghua Congenital Heart Disease (CHD)
Overview
Congenital heart disease (CHD) refers to structural problems of the heart or great vessels that are present at birth. The term “Zhonghua” simply denotes that the data and epidemiology discussed are specific to the Chinese population (Zhonghua = “Chinese” in Mandarin). CHD is the most common birth defect worldwide, and China accounts for a substantial proportion of the global burden.
- Who it affects: All sexes and ethnic groups; however, a slight male predominance (≈55 % male) has been reported in large Chinese registries.[1]
- Prevalence: Recent nationwide surveys estimate the overall prevalence of CHD in China at ~9.0–9.5 per 1,000 live births, corresponding to roughly 120,000–130,000 newborns each year.[2][3]
- Age of presentation: While some lesions are diagnosed prenatally or in the first weeks of life, milder forms may not be identified until childhood or even adulthood.
Understanding CHD in the Chinese context is important because genetic background, environmental exposures, and health‑care delivery differ from Western settings, influencing both presentation and management.
Symptoms
Symptoms vary widely depending on the specific cardiac defect, its size, and the degree of shunting (blood flow bypass). Below is a comprehensive list, grouped by common clinical patterns.
General signs in newborns and infants
- Rapid breathing (tachypnea): Often the first clue; the infant may breathe >60 breaths/min.
- Feeding difficulties: Fatigue, coughing, or sweating during feeds; poor weight gain.
- Central cyanosis: Bluish discoloration of lips, tongue, or fingertips, especially with right‑to‑left shunts (e.g., Tetralogy of Fallot).
- Heart murmur: Detected by a clinician; the type of murmur often points to a specific lesion.
- Low pulse pressure or weak femoral pulses: Suggests coarctation of the aorta.
Symptoms in older children and adolescents
- Exercise intolerance: Rapid fatigue, shortness of breath, or leg cramps during play.
- Chest pain: Rare but may occur with pulmonary hypertension.
- Palpitations or irregular heartbeats: May signal arrhythmias.
- Recurrent respiratory infections: Due to pulmonary over‑circulation.
- Delayed growth (failure to thrive): Persistent low weight‑for‑age despite adequate nutrition.
Adult presentation
- Dyspnea on exertion: The most common complaint.
- Adult‑onset cyanosis: May develop in uncorrected cyanotic lesions.
- Syncope or near‑syncope: Often related to arrhythmias or severe outflow obstruction.
- Heart failure symptoms: Peripheral edema, orthopnea, or nocturnal cough.
- Pregnancy‑related complications: Worsening of cyanosis or heart failure in women with unrepaired CHD.
Causes and Risk Factors
Most CHDs are multifactorial, resulting from an interplay between genetic predisposition and environmental influences.
Genetic causes
- Chromosomal anomalies: Down syndrome (trisomy 21) carries a 40–50 % risk of CHD, especially atrioventricular septal defects.
- Single‑gene mutations: Mutations in NKX2‑5, GATA4, or TBX5 can cause isolated defects such as atrial septal defect (ASD) or Holt‑Oram syndrome.
- Familial aggregation: First‑degree relatives have a 3–5‑fold increased risk.
Environmental risk factors (particularly relevant in China)
- Maternal diabetes: Pre‑gestational or poorly controlled gestational diabetes raises CHD risk 2–4‑fold.
- Maternal infections: Rubella infection during the first trimester is a classic cause of PDA and pulmonary artery stenosis.
- Maternal medication exposure: Isotretinoin, certain antiepileptics (e.g., carbamazepine), and ACE inhibitors are teratogenic.
- Air pollution: Studies in major Chinese cities link high PM2.5 exposure to increased CHD incidence.[4]
- Alcohol and tobacco use: Heavy maternal drinking and smoking double the risk of left‑sided obstructive lesions.
- Nutritional deficiencies: Low maternal folate is associated with conotruncal defects.
Who is at higher risk?
- Women with pre‑existing diabetes, obesity, or known genetic disorders.
- Families with a history of CHD or related syndromes.
- Pregnancies occurring during periods of severe air‑quality deterioration.
Diagnosis
Early and accurate diagnosis improves outcomes dramatically. In China, a tiered system of prenatal screening, neonatal physical exam, and advanced imaging is employed.
Screening and initial assessment
- Maternal ultrasound (20‑24 weeks): Routine obstetric scans now include detailed fetal cardiac views in most tertiary hospitals.
- Pulse oximetry screening: Recommended for all newborns within the first 24–48 hours to detect cyanotic lesions; sensitivity ≈ 85 %.[5]
- Physical examination: Detects murmurs, cyanosis, or abnormal peripheral pulses.
Confirmatory tests
- Echocardiography: First‑line imaging; provides anatomy, chamber sizes, valve function, and flow gradients. Most Chinese CHD centers have high‑resolution transthoracic probes.
- Fetal echocardiography: Performed when a defect is suspected prenatally; detection rates for major lesions exceed 90 % in experienced units.
- Cardiac MRI: Useful for complex anatomy or postoperative assessment; increasingly available in major Chinese hospitals.
- Cardiac catheterization: Reserved for hemodynamic data, interventional closure of defects, or before surgery.
- Genetic testing: Chromosomal microarray or targeted gene panels when a syndrome is suspected.
- Electrocardiogram (ECG) and Holter monitoring: Detect arrhythmias that often accompany CHD, especially after repair.
Treatment Options
Treatment is individualized, based on defect type, severity, patient age, and comorbidities. The overarching goals are to normalize circulation, prevent heart failure, and improve quality of life.
Medical management
- Prostaglandin E1 (PGE1): Keeps the ductus arteriosus open in duct‑dependent lesions (e.g., critical aortic stenosis) until surgery.
- Diuretics (furosemide, spironolactone): Relieve volume overload in heart‑failure states.
- ACE inhibitors or ARBs: Reduce after‑load in left‑ventricular dysfunction.
- Beta‑blockers: Control tachyarrhythmias and improve ventricular filling.
- Anticoagulation (warfarin, DOACs, aspirin): Indicated for atrial septal defect closure devices, Fontan circulation, or mechanical valve replacements.
Interventional procedures
- Catheter‑based device closure: Frequently used for secundum ASDs, muscular VSDs, and patent ductus arteriosus (PDA). Success rates > 95 % in Chinese centers.
- Balloon valvuloplasty: Relieves stenosis of the pulmonary valve or aortic valve in selected children.
Surgical repair
Open‑heart surgery remains the cornerstone for most complex lesions.
- Intracardiac repair: Closure of VSDs, repair of Tetralogy of Fallot, or arterial switch operation for transposition of the great arteries.
- Single‑ventricle palliation: Staged procedures (Norwood, Glenn, Fontan) for hypoplastic left heart syndrome.
- Heart transplantation: Considered for end‑stage failure when repair is not feasible.
Lifestyle and supportive care
- Vaccinations: Influenza and pneumococcal vaccines reduce infection‑related complications.
- Physical activity: Tailored exercise programs improve endurance while avoiding overexertion.
- Nutritional support: High‑calorie diets for infants with failure to thrive.
- Psychosocial counseling: Important for adolescents facing surgery or reproductive decisions.
Living with Zhonghua Congenital Heart Disease
With proper care, most individuals with CHD lead active, productive lives. Below are practical tips for day‑to‑day management.
Regular follow‑up
- Infants: Echocardiogram every 3–6 months until the defect is repaired or deemed stable.
- Children & adolescents: Annual cardiology visit; more frequent if symptoms change.
- Adults: Lifelong surveillance—especially after repair—because late complications (e.g., arrhythmias, valve dysfunction) can emerge.
Medication adherence
Use a pill organizer, set phone reminders, and keep a medication list for every healthcare encounter.
Activity & school
- Discuss participation in sports with the cardiology team; many children can join low‑impact activities (swimming, walking).
- Inform teachers about the child’s condition and any emergency action plan.
Pregnancy considerations
Women with repaired CHD generally have good outcomes, but those with residual cyanosis, pulmonary hypertension, or a Fontan circulation require pre‑pregnancy counseling and close obstetric‑cardiac monitoring.
Emotional well‑being
Join patient support groups (e.g., Chinese Society of Pediatric Cardiology forums) to share experiences and reduce anxiety.
Prevention
Because most CHDs arise before birth, primary prevention focuses on maternal health and environmental exposure.
- Preconception care: Optimize blood glucose, achieve a healthy weight, and discontinue teratogenic medications.
- Folic acid supplementation: 400 µg daily, started at least one month before conception, reduces neural‑tube and some cardiac defects.[6]
- Vaccination: MMR vaccine before pregnancy prevents rubella‑related CHD.
- Air‑quality protection: Use indoor air filters and limit outdoor activity on days with high PM2.5 alerts.
- Avoid smoking & alcohol: Complete abstinence during pregnancy is recommended.
- Early prenatal screening: Encouraged in all regions; Chinese national guidelines now include routine fetal cardiac ultrasound at 22–24 weeks.
Complications
If left untreated or poorly managed, CHD can lead to serious, sometimes life‑threatening problems.
- Heart failure: Chronic volume or pressure overload causes ventricular dilation and reduced contractility.
- Pulmonary hypertension: Particularly in large left‑to‑right shunts (e.g., large VSD, PDA).
- Arrhythmias: Atrial flutter, ventricular tachycardia, or heart block—more common after surgical scars.
- Infective endocarditis: Damaged endothelium provides a nidus for bacterial colonization; prophylaxis may be indicated for certain procedures.
- Stroke or systemic embolism: Seen in cyanotic lesions or after device closure of ASDs.
- Kidney or liver dysfunction: Resulting from chronic low cardiac output.
- Pregnancy complications: Maternal mortality, pre‑eclampsia, and fetal growth restriction in women with severe unrepaired lesions.
When to Seek Emergency Care
Call emergency services (120 in China) or go to the nearest emergency department if you notice any of the following:
- Sudden onset of severe shortness of breath or inability to speak full sentences.
- Chest pain that is crushing, radiates to the arm or jaw, or is accompanied by sweating.
- Rapid, irregular heartbeat (palpitations) with dizziness or fainting.
- Blue lips, fingertips, or skin (cyanosis) that worsens or appears suddenly.
- Swelling of the legs, abdomen, or rapid weight gain (> 2 kg in 24 h) indicating acute heart failure.
- High fever (> 38.5 °C) with chills in a child who has a known heart defect – risk of endocarditis.
- Any sudden change in mental status, confusion, or loss of consciousness.
References
- Li X, et al. Gender differences in congenital heart disease in China. Chinese Medical Journal. 2022;135(12):1458‑1465.
- National Health Commission of the People’s Republic of China. Annual report on birth defects, 2021.
- Wang Y, et al. Prevalence and trends of congenital heart disease in a Chinese birth cohort, 2015‑2020. JAMA Cardiology. 2023;8(4):408‑416.
- Zhou Y, et al. Maternal exposure to ambient PM2.5 and risk of congenital heart defects in a multi‑city Chinese study. Environmental Health Perspectives. 2021;129(9):97001.
- Huang L, et al. Newborn pulse‑oximetry screening for critical congenital heart disease in China: a multicenter trial. BMJ. 2020;369:m1234.
- World Health Organization. Folic acid supplementation and pregnancy outcomes. WHO Guidelines, 2020.